All Stories

  1. Strategies to prevent post-transplant relapse in acute myeloid leukemia and myelodysplastic syndromes

    Article • International Journal of Hematology, September 2026, Springer Science + Business Media

    Dr Yuho Najima

  2. Outcomes of two or more rounds of hematopoietic stem cell transplantation using total body irradiation for hematological malignancies

    Article • Radiotherapy and Oncology, September 2026, Elsevier

    Dr Yuho Najima

  3. Quizartinib Resistance Mutations and Treatment Outcomes in Relapsed or Refractory FLT3 ‐ ITD –Positive AML

    Article • Cancer Science, August 2026, Wiley

    Dr Yuho Najima

  4. Case Report: Immune-directed post-transplant maintenance with low-dose gemtuzumab ozogamicin and stepwise donor lymphocyte infusion in acute myeloid leukemia with t(1;3)(p36.3;q21)

    Article • Frontiers in Immunology, August 2026, Frontiers

    Dr Yuho Najima

  5. Case Report: Immune-driven clonal selection underlying lineage switch from B-Precursor acute lymphoblastic leukemia to acute myeloid leukemia following inotuzumab ozogamicin

    Article • Frontiers in Immunology, July 2026, Frontiers

    Dr Yuho Najima

  6. Chronic neutrophilic leukemia with transformation to B-lymphoblastic leukemia

    Article • Leukemia Research, July 2026, Elsevier

    Dr Yuho Najima

  7. Absence of Pretransplant Peripheral Blasts is Favorable Factor in Allogeneic Stem Cell Transplantation for Advanced Acute Lymphoblastic Leukemia

    Article • Transplantation and Cellular Therapy, June 2026, Elsevier

    Dr Yuho Najima

  8. Changes in Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for FLT3-ITD-mutated Acute Myeloid Leukemia in the FLT3 Inhibitor Era

    Article • Clinical Lymphoma Myeloma & Leukemia, June 2026, Elsevier

    Dr Yuho Najima

  9. Treatment Outcomes of Adult B-Cell Acute Lymphoblastic Leukemia with Post-Transplant Relapse in the Era of Immunotherapeutic Agents

    Article • Transplantation and Cellular Therapy, May 2026, Elsevier

    Dr Yuho Najima

  10. Vaccine-Induced Anti-HBs Response is Associated with Protection Against Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Cell Transplantation: A Randomized Trial

    Article • Transplantation and Cellular Therapy, May 2026, Elsevier

    Dr Yuho Najima

  11. Significant clinical impact of immunosuppressive therapy termination after allogeneic haematopoietic stem cell transplantation

    Article • British Journal of Haematology, March 2026, Wiley

    Dr Yuho Najima

  12. Prognostic Impact of BK Polyomavirus Viremia Detected by Multiplex Plasma PCR Following Allogeneic Hematopoietic Cell Transplantation

    Article • Transplantation and Cellular Therapy, March 2026, Elsevier

    Dr Yuho Najima

  13. CXCR4 induces memory formation over exhaustion in CAR-T cells to achieve durable leukemia targeting

    Article • Nature Communications, January 2026, Springer Science + Business Media

    Dr Yuho Najima

  14. NGS-based quantitative typing to identify HLA loss relapse after allogeneic stem cell transplantation

    Article • Leukemia Research, January 2026, Elsevier

    Dr Yuho Najima

  15. Novel Scoring System Using Geriatric Nutritional Risk Index, C-Reactive Protein, and Disease Status Predicts Survival After Second Allogeneic Stem Cell Transplantation

    Article • Transplantation and Cellular Therapy, December 2025, Elsevier

    Dr Yuho Najima

  16. HCT-VTE-J Model to Predict Late-Onset Venous Thromboembolism after Allogeneic Hematopoietic Stem Cell Transplantation: A Japanese Single-Center Study

    Article • Transplantation and Cellular Therapy, December 2025, Elsevier

    Dr Yuho Najima

  17. A Phase 2 study of sequential administration of gilteritinib after MEC chemotherapy in Relapsed/Refractory FLT3-mutated Acute Myeloid Leukemia in adults: Japan adult leukemia study group (JALSG) RR-FLT3-AML220 study

    Article • Blood, November 2025, American Society of Hematology

    Dr Yuho Najima

  18. Effect of FLT3 maintenance in older FLT3-ITD+ adults undergoing allogeneic HCT. a post hoc analysis of BMT CTN 1506

    Article • Blood, November 2025, American Society of Hematology

    Dr Yuho Najima

  19. Nelarabine treatment before allogeneic stem cell transplantation was associated with an increased risk of neurological adverse events in patients with T-ALL/lbl: A retrospective study of the kanto study group for cell therapy.

    Article • Blood, November 2025, American Society of Hematology

    Dr Yuho Najima

  20. Poor neutrophil recovery following CD19-targeted CAR-T cell therapy predicts inferior outcomes in adult patients with B-cell lymphoma

    Article • Blood, November 2025, American Society of Hematology

    Dr Yuho Najima

  21. Serum albumin, but not gnri, is an independent prognostic factor for survival after first allogeneic SCT: A large-scale multicenter analysis

    Article • Blood, November 2025, American Society of Hematology

    Dr Yuho Najima

  22. TP53, EZH2, or RUNX1 mutations predict poor outcomes in ELN 2022 adverse risk group of adult AML patients undergoing allo-HSCT

    Article • Blood, November 2025, American Society of Hematology

    Dr Yuho Najima

  23. Time from AML diagnosis to HCT and pre-HCT FLT3 inhibition impact pre-transplant MRD and benefit from post-HCT gilteritinib

    Article • Blood, November 2025, American Society of Hematology

    Dr Yuho Najima

  24. Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia

    Article • Blood Advances, October 2025, American Society of Hematology

    Dr Yuho Najima

  25. Real‐World Efficacy of Extending Duration of Letermovir Prophylaxis for Allogeneic Stem Cell Recipients

    Article • Transplant Infectious Disease, October 2025, Wiley

    Dr Yuho Najima

  26. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Myeloid Malignancies Over 70 Years Old: A Retrospective Analysis of the Japanese Nationwide Registry

    Article • Transplantation and Cellular Therapy, October 2025, Elsevier

    Dr Yuho Najima

  27. Impact of prior solid tumors and their treatment modality on outcomes after allogeneic hematopoietic stem cell transplantation

    Article • Bone Marrow Transplantation, September 2025, Springer Science + Business Media

    Dr Yuho Najima

  28. Prognostic Value of C‐Reactive Protein/Platelet Ratio as a Biomarker Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Malignant Lymphoma

    Article • Hematological Oncology, September 2025, Wiley

    Dr Yuho Najima

  29. Ponatinib/blinatumomab for relapsed Philadelphia chromosome-positive leukemia as a bridge to allogeneic transplantation

    Article • Hematology, July 2025, Taylor & Francis

    Dr Yuho Najima

  30. Recent Advances in the Prognosis of HHV-6 Encephalitis Following Allogeneic Hematopoietic Stem Cell Transplantation

    Article • Transplantation and Cellular Therapy, July 2025, Elsevier

    Dr Yuho Najima

  31. Distinct impact of letermovir discontinuation on tacrolimus pharmacokinetics based on concomitant azole antifungal agent

    Article • International Journal of Hematology, June 2025, Springer Science + Business Media

    Dr Yuho Najima

  32. Real‐World Practice and Challenges of Donor Lymphocyte Apheresis and Infusion: A Single‐Center Experience

    Article • Therapeutic Apheresis and Dialysis, June 2025, Wiley

    Dr Yuho Najima

  33. Pre-transplant blinatumomab and/or inotuzumab ozogamicin therapy for relapsed/refractory acute lymphoblastic and B/myeloid mixed phenotype acute leukemia in adults

    Article • Leukemia Research, June 2025, Elsevier

    Dr Yuho Najima

  34. Noninvasive visualization of neutropenic enterocolitis using capsule endoscopy

    Article • Endoscopy, May 2025, Thieme Publishing Group

    Dr Yuho Najima

  35. Improved non-relapse mortality in allogeneic hematopoietic stem cell transplantation: a long-standing multidisciplinary pursuit at a single center

    Article • Bone Marrow Transplantation, May 2025, Springer Science + Business Media

    Dr Yuho Najima

  36. Classical and Late‐Onset SOS/VOD After Allogeneic HSCT: A Japanese Transplant Registry Analysis

    Article • American Journal of Hematology, May 2025, Wiley

    Dr Yuho Najima

  37. Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD –mutated AML

    Article • Blood, May 2025, American Society of Hematology

    Dr Yuho Najima

  38. Drug‐induced liver injury due to granulocyte colony‐stimulating factor in a healthy donor for allogeneic peripheral blood stem cell transplantation

    Article • Vox Sanguinis, April 2025, Wiley

    Dr Yuho Najima

  39. Diamond–Blackfan anemia syndrome in an adult with RPS19 and DDX41 variants successfully treated with allogeneic stem cell transplantation: a case report

    Article • Leukemia & Lymphoma, April 2025, Taylor & Francis

    Dr Yuho Najima

  40. Impact of DTaP-IPV and DTaP Vaccination Among Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients: A Prospective Observational Study

    Article • Vaccines, March 2025, MDPI AG

    Dr Yuho Najima

  41. Transplantation outcomes of TP53-mutant AML and MDS: a single transplantation center experience of 63 patients

    Article • International Journal of Hematology, February 2025, Springer Science + Business Media

    Dr Yuho Najima

  42. Outcome of donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation in relapsed myelodysplastic syndrome

    Article • Cytotherapy, February 2025, Elsevier

    Dr Yuho Najima

  43. Changes in donor lymphocyte infusion for relapsed patients post-hematopoietic stem cell transplantation: a 30-year single-center experience

    Article • Frontiers in Immunology, January 2025, Frontiers

    Dr Yuho Najima

  44. Telomere shortening in donor cell-derived acute promyelocytic leukemia after allogeneic hematopoietic stem cell transplantation: a case report

    Article • Annals of Hematology, January 2025, Springer Science + Business Media

    Dr Yuho Najima

  45. 774P High MTV and low CD4/CD8 ratio before apheresis are poor prognostic factors in patients with r/r LBCL treated with CAR T-cell therapy

    Article • Annals of Oncology, December 2024, Elsevier

    Dr Yuho Najima

  46. Treatment Outcomes of Adult Patients with B-Cell Acute Lymphoblastic Leukemia Relapsed after Allogeneic Stem Cell Transplant in the Era of Novel Immunochemotherapeutic Agents

    Article • Blood, November 2024, American Society of Hematology

    Dr Yuho Najima

  47. Quizartinib with donor lymphocyte infusion for post-transplant relapse of FLT3-ITD-positive acute myeloid leukemia

    Article • International Journal of Hematology, October 2024, Springer Science + Business Media

    Dr Yuho Najima

  48. Improving cellular therapy operations through pre‐harvest measurement of peripheral CD34‐positive cell counts in allogeneic stem cell harvest

    Article • Therapeutic Apheresis and Dialysis, August 2024, Wiley

    Dr Yuho Najima

  49. Lower-dose post-transplant cyclophosphamide in haploidentical hematopoietic cell transplantation

    Article • Bone Marrow Transplantation, August 2024, Springer Science + Business Media

    Dr Yuho Najima

  50. Overcoming post‐transplant graft failure and adenovirus infection in a patient with FLT3‐TKD‐mutated mixed‐phenotype acute leukemia: A case report

    Article • eJHaem, June 2024, Wiley

    Dr Yuho Najima

  51. Successful treatment of two cases with Philadelphia-chromosome positive acute lymphoblastic leukemia who relapsed after allogeneic stem cell transplantation and the treatments with novel immunotherapies and ponatinib

    Article • Hematology, June 2024, Taylor & Francis

    Dr Yuho Najima

  52. Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignancies

    Article • Bone Marrow Transplantation, May 2024, Springer Science + Business Media

    Dr Yuho Najima

  53. Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3

    Article • Journal of Clinical Oncology, May 2024, American Society of Clinical Oncology (ASCO)

    Dr Yuho Najima

  54. Effectiveness and safety of granulocyte colony-stimulating factor priming regimen for acute myeloid leukemia: A systematic review and meta-analysis of the Clinical Practice Guideline for the use of G-CSF 2022 from the Japan Society of Clinical Oncology

    Article • International Journal of Clinical Oncology, May 2024, Springer Science + Business Media

    Dr Yuho Najima

  55. Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology

    Article • International Journal of Clinical Oncology, March 2024, Springer Science + Business Media

    Dr Yuho Najima

  56. Outcomes of Cessation of Nucleos(t)ide Analog Administration on Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Retrospective Study

    Article • Transplantation and Cellular Therapy, March 2024, Elsevier

    Dr Yuho Najima

  57. Recurrent DDX41 mutation in very late relapse after allogeneic stem cell transplantation

    Article • Leukemia, January 2024, Springer Science + Business Media

    Dr Yuho Najima

  58. Case report: Immune pressure on hematopoietic stem cells can drastically expand glycosylphosphatidylinositol-deficient clones in paroxysmal nocturnal hemoglobinuria

    Article • Frontiers in Immunology, January 2024, Frontiers

    Dr Yuho Najima

  59. Early failure is still a poor prognostic factor in patients with relapsed or refractory large B-cell lymphoma in the era of CAR T-cell therapy

    Article • Journal of Clinical and Experimental Hematopathology, January 2024, Japanese Society for Lymphoreticular Tissue Research

    Dr Yuho Najima

  60. Elevation of Urinary Liver-Type Fatty Acid-Binding Protein Is a Harbinger of Poor Patient Prognosis after Allogeneic Stem Cell Transplantation

    Article • Transplantation and Cellular Therapy, January 2024, Elsevier

    Dr Yuho Najima

  61. Clinical significance of late CMV disease in adult patients who underwent allogeneic stem cell transplant

    Article • Journal of Infection and Chemotherapy, December 2023, Elsevier

    Dr Yuho Najima

  62. Low‐ versus standard‐dose post‐transplant cyclophosphamide as GVHD prophylaxis for haploidentical transplantation

    Article • British Journal of Haematology, November 2023, Wiley

    Dr Yuho Najima

  63. Development and evaluation of a rapid one-step high sensitivity real-time quantitative PCR system for minor BCR-ABL (e1a2) test in Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)

    Article • Japanese Journal of Clinical Oncology, November 2023, Oxford University Press (OUP)

    Dr Yuho Najima

  64. Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignancies

    Article • November 2023, Research Square

    Dr Yuho Najima

  65. A Novel Scoring System Using Geriatric Nutritional Risk Index, C-Reactive Protein, and Disease Status Predicts Survival after Second Allogeneic Stem Cell Transplantation

    Article • Blood, November 2023, American Society of Hematology

    Dr Yuho Najima

  66. Outcomes after Hematopoietic Cell Transplantation for T-Lineage Acute Lymphoblastic Leukemia and Lymphoma: A Cooperative Study from the Adult Acute Lymphoblastic Leukemia Working Group and the Adult Malignant Lymphoma Working Group of the Japanese Soci...

    Article • Blood, November 2023, American Society of Hematology

    Dr Yuho Najima

  67. Outcomes and Prognostic Factors of Second Allogeneic Hematopoietic Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: A Study from the Adult Acute Lymphoblastic Leukemia Working Group of the Japanese Society for Transplantation and Cel...

    Article • Blood, November 2023, American Society of Hematology

    Dr Yuho Najima

  68. Post-Hoc Analysis of Measurable Residual Disease from BMT-CTN 1506/Morpho: FLT3-ITD Variant Allele Frequency and Survival Are Highly Correlated

    Article • Blood, November 2023, American Society of Hematology

    Dr Yuho Najima

  69. Recurrence of HBV Reactivation after Allogeneic Hematopoietic Transplantation in Recipients with Resolved HBV Infection: A Nation-Wide Multicenter Retrospective Study

    Article • Blood, November 2023, American Society of Hematology

    Dr Yuho Najima

  70. Venetoclax-Based Therapy before Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia

    Article • Blood, November 2023, American Society of Hematology

    Dr Yuho Najima

  71. Clinical outcomes in transplant‐eligible patients with relapsed or refractory diffuse large B‐cell lymphoma after second‐line salvage chemotherapy: A retrospective study

    Article • Cancer Medicine, August 2023, Wiley

    Dr Yuho Najima

  72. Identification of compounds that preferentially suppress the growth of T‐cell acute lymphoblastic leukemia‐derived cells

    Article • Cancer Science, July 2023, Wiley

    Dr Yuho Najima

  73. Overcoming relapse: prophylactic or pre-emptive use of azacitidine or FLT3 inhibitors after allogeneic transplantation for AML or MDS

    Article • International Journal of Hematology, April 2023, Springer Science + Business Media

    Dr Yuho Najima

  74. Clinical impact and early prediction of carbapenem-resistant Pseudomonas aeruginosa bacteraemia in allogeneic hematopoietic stem cell transplantation recipients

    Article • Journal of Global Antimicrobial Resistance, March 2023, Elsevier

    Dr Yuho Najima

  75. Different effects of thymoglobulin on acute leukemia with pre-transplant residual blasts in HLA mismatch transplantation

    Article • International Journal of Hematology, February 2023, Springer Science + Business Media

    Dr Yuho Najima

  76. Impact of gene alterations on clinical outcome in young adults with myelodysplastic syndromes

    Article • Scientific Reports, February 2023, Springer Science + Business Media

    Dr Yuho Najima

  77. Importance of TKI treatment duration in treatment-free remission of chronic myeloid leukemia: results of the D-FREE study

    Article • International Journal of Hematology, February 2023, Springer Science + Business Media

    Dr Yuho Najima

  78. Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemia

    Article • Cancer Science, January 2023, Wiley

    Dr Yuho Najima

  79. A third dose of COVID‐19 mRNA vaccine induces limited humoral response in stem cell transplant recipients who got two vaccine doses before transplant

    Article • eJHaem, December 2022, Wiley

    Dr Yuho Najima

  80. Central nervous system mucormycosis in a patient with hematological malignancy: A case report and review of the literature

    Article • Journal of Infection and Chemotherapy, December 2022, Elsevier

    Dr Yuho Najima

  81. Mutational Analysis of DNMT3A Improves the Prognostic Stratification Using NPM1/FLT3-ITD Genotypes in Patients with Acute Myeloid Leukemia

    Article • Blood, November 2022, American Society of Hematology

    Dr Yuho Najima

  82. Novel Prediction Models of Nonrelapse Mortality in Patients Specific to Each Reduced-Intensity Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Analysis from the Kanto Study Group for Cell Therapy (KSGCT)

    Article • Blood, November 2022, American Society of Hematology

    Dr Yuho Najima

  83. Outcomes of allogeneic haematopoietic stem cell transplantation with intensity-modulated total body irradiation by helical tomotherapy: a 2-year prospective follow-up study

    Article • Annals of Medicine, October 2022, Taylor & Francis

    Dr Yuho Najima

  84. Phase I trial of myeloablative conditioning with three‐day total marrow and lymphoid irradiation for leukemia

    Article • Cancer Science, October 2022, Wiley

    Dr Yuho Najima

  85. Attenuated humoral response against SARS‐CoV ‐2 mRNA vaccination in allogeneic stem cell transplantation recipients

    Article • Cancer Science, October 2022, Wiley

    Dr Yuho Najima

  86. Dose-finding trial of azacitidine as post-transplant maintenance for high-risk MDS: a KSGCT prospective study

    Article • Annals of Hematology, September 2022, Springer Science + Business Media

    Dr Yuho Najima

  87. Labile CD22 and CD19 expression in a case of Philadelphia chromosome-like acute lymphoblastic leukemia

    Article • Leukemia & Lymphoma, September 2022, Taylor & Francis

    Dr Yuho Najima

  88. Weight-adjusted urinary creatinine excretion predicts transplant outcomes in adult patients with acute myeloid leukemia in complete remission

    Article • Leukemia & Lymphoma, September 2022, Taylor & Francis

    Dr Yuho Najima

  89. Impact of lung function impairment after allogeneic hematopoietic stem cell transplantation

    Article • Scientific Reports, August 2022, Springer Science + Business Media

    Dr Yuho Najima

  90. Immunological influence of serum-free manufactured umbilical cord-derived mesenchymal stromal cells for steroid-resistant acute graft-versus-host disease

    Article • International Journal of Hematology, July 2022, Springer Science + Business Media

    Dr Yuho Najima

  91. Outcomes of salvage haploidentical transplantation using posttransplant cyclophosphamide for graft failure following allogeneic hematopoietic stem cell transplantation

    Article • International Journal of Hematology, June 2022, Springer Science + Business Media

    Dr Yuho Najima

  92. Allogeneic Hematopoietic Stem Cell Transplantation for Adult Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia in Second Complete Remission

    Article • Transplantation and Cellular Therapy, June 2022, Elsevier

    Dr Yuho Najima

  93. Myeloablative Versus Reduced-Intensity Conditioning With Fludarabine/Busulfan for Myelodysplastic Syndrome: A Propensity Score-Matched Analysis

    Article • Transplantation and Cellular Therapy, June 2022, Elsevier

    Dr Yuho Najima

  94. NPM1-mutation-based measurable residual disease assessment after completion of two courses of post-remission therapy is a valuable clinical predictor of the prognosis of acute myeloid leukemia

    Article • International Journal of Hematology, April 2022, Springer Science + Business Media

    Dr Yuho Najima

  95. Cyclophosphamide‐induced cardiotoxicity at conditioning for allogeneic hematopoietic stem cell transplantation would occur among the patients treated with 120 mg/kg or less

    Article • Asia-Pacific Journal of Clinical Oncology, March 2022, Wiley

    Dr Yuho Najima

  96. Prognostic factors of children and adolescents with T‐cell acute lymphoblastic leukemia after allogeneic transplantation

    Article • Hematological Oncology, March 2022, Wiley

    Dr Yuho Najima

  97. Antithymocyte Globulin Potentially Could Overcome an Adverse Effect of Acute Graft-versus-Host Disease in Matched-Related Peripheral Blood Stem Cell Transplantation

    Article • Transplantation and Cellular Therapy, March 2022, Elsevier

    Dr Yuho Najima

  98. Letter to the Editor: Very low-dose antithymocyte globulin (thymoglobulin) is effective for steroid-refractory acute graft-versus-host disease involving the skin or gut after allogeneic hematopoietic stem cell transplantation

    Article • International Journal of Hematology, January 2022, Springer Science + Business Media

    Dr Yuho Najima

  99. Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia

    Article • Blood Advances, January 2022, American Society of Hematology

    Dr Yuho Najima

  100. Donor lymphocyte infusion after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia

    Article • Annals of Hematology, January 2022, Springer Science + Business Media

    Dr Yuho Najima

  101. Paraplegia via hematogenous dissemination of Cunninghamella elegans (mucormycosis) after hematopoietic stem cell transplantation

    Article • International Journal of Infectious Diseases, December 2021, Elsevier

    Dr Yuho Najima

  102. Chimeric antigen receptor T-cell therapy following autologous transplantation for secondary central nervous system lymphoma

    Article • Medicine, November 2021, Wolters Kluwer Health

    Dr Yuho Najima

  103. Clinical, Cytogenetic, and Molecular Characteristics Analysis in Myelodysplastic Syndromes with Elevated Ferritin Levels

    Article • Blood, November 2021, American Society of Hematology

    Dr Yuho Najima

  104. Comparison of Myeloablative Versus Reduced-Intensity Fludarabine/Busulfan Regimen in Patients with Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

    Article • Blood, November 2021, American Society of Hematology

    Dr Yuho Najima

  105. Importance of the Duration of TKI Treatment in Treatment-Free Remission of Chronic Phase Chronic Myeloid Leukemia: Results of D-Free Trial

    Article • Blood, November 2021, American Society of Hematology

    Dr Yuho Najima

  106. Outcomes of Haploidentical Salvage Transplantation Using Post-Transplant Cyclophosphamide for Graft Failure Following Allogeneic Hematopoietic Stem Cell Transplantation

    Article • Blood, November 2021, American Society of Hematology

    Dr Yuho Najima

  107. Prognostic Impacts of Additional Cytogenetic Abnormalities Acquired at the First Relapse in Adult Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplant in Second Complete Remission

    Article • Blood, November 2021, American Society of Hematology

    Dr Yuho Najima

  108. Retrospective comparison of hematopoietic stem cell transplantation following reduced-intensity conditioning with fludarabine/low-dose melphalan plus 4 Gy TBI versus fludarabine/ busulfan plus 4 Gy TBI

    Article • International Journal of Hematology, October 2021, Springer Science + Business Media

    Dr Yuho Najima

  109. Mutation profiles of diffuse large B‐cell lymphoma transformation of splenic B‐cell lymphoma/leukemia, unclassifiable on whole‐exome sequencing

    Article • eJHaem, October 2021, Wiley

    Dr Yuho Najima

  110. Fludarabine/busulfan versus busulfan/cyclophosphamide as myeloablative conditioning for myelodysplastic syndrome: a propensity score-matched analysis

    Article • Bone Marrow Transplantation, September 2021, Springer Science + Business Media

    Dr Yuho Najima

  111. Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center study

    Article • Leukemia Research, September 2021, Elsevier

    Dr Yuho Najima

  112. Pre-conditioning intervention in patients with relapsed or refractory acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation: a KSGCT multicenter retrospective analysis

    Article • Annals of Hematology, August 2021, Springer Science + Business Media

    Dr Yuho Najima

  113. Donor‐derived gene mutations in sex chromosome loss after stem cell transplantation

    Article • British Journal of Haematology, July 2021, Wiley

    Dr Yuho Najima

  114. MPL overexpression induces a high level of mutant-CALR/MPL complex: a novel mechanism of ruxolitinib resistance in myeloproliferative neoplasms with CALR mutations

    Article • International Journal of Hematology, June 2021, Springer Science + Business Media

    Dr Yuho Najima

  115. Prognostic factors in salvage transplantation for graft failure following allogeneic hematopoietic stem cell transplantation

    Article • Bone Marrow Transplantation, April 2021, Springer Science + Business Media

    Dr Yuho Najima

  116. Changes in vaccination strategies contribute to the development of invasive pneumococcal disease in allogeneic hematopoietic stem cell transplantation recipients: a retrospective study for promoting vaccination

    Article • International Journal of Hematology, April 2021, Springer Science + Business Media

    Dr Yuho Najima

  117. Low diversity of gut microbiota in the early phase of post-bone marrow transplantation increases the risk of chronic graft-versus-host disease

    Article • Bone Marrow Transplantation, March 2021, Springer Science + Business Media

    Dr Yuho Najima

  118. Effect of methotrexate dose in graft-versus-host disease prophylaxis after single-unit cord blood transplantation in adult acute myeloid leukemia

    Article • International Journal of Hematology, February 2021, Springer Science + Business Media

    Dr Yuho Najima

  119. A multicenter phase II study of intrabone single-unit cord blood transplantation without antithymocyte globulin

    Article • Annals of Hematology, January 2021, Springer Science + Business Media

    Dr Yuho Najima

  120. Successful Cord Blood Transplantation for Idiopathic CD4<sup>+</sup> Lymphocytopenia

    Article • Acta Haematologica, January 2021, Karger Publishers

    Dr Yuho Najima

  121. Clinical Benefits of Preconditioning Intervention in Patients with Relapsed or Refractory Acute Myelogenous Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A Kanto Study of Group for Cell Therapy Multicenter Analysis

    Article • Transplantation and Cellular Therapy, January 2021, Elsevier

    Dr Yuho Najima

  122. T-cell receptor repertoire of cytomegalovirus-specific cytotoxic T-cells after allogeneic stem cell transplantation

    Article • Scientific Reports, December 2020, Springer Science + Business Media

    Dr Yuho Najima

  123. Intraventricular rupture of Aspergillus brain abscess during remission induction

    Article • International Journal of Infectious Diseases, December 2020, Elsevier

    Dr Yuho Najima

  124. Novel Prediction Models of Nonrelapse Mortality in Patients Specific to Each Myeloablative Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation: A Multicenter Analysis from the Kanto Study Group for Cell Therapy (KSGCT)

    Article • Blood, November 2020, American Society of Hematology

    Dr Yuho Najima

  125. Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantation

    Article • Blood Advances, September 2020, American Society of Hematology

    Dr Yuho Najima

  126. Safety of total body irradiation using intensity-modulated radiation therapy by helical tomotherapy in allogeneic hematopoietic stem cell transplantation: a prospective pilot study

    Article • Journal of Radiation Research, September 2020, Oxford University Press (OUP)

    Dr Yuho Najima

  127. Use of unapproved or off-label drugs in Japan for the treatment of graft-versus-host disease and post-transplant viral infection

    Article • International Journal of Hematology, September 2020, Springer Science + Business Media

    Dr Yuho Najima

  128. The impacts of BCR-ABL1 mutations in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia who underwent allogeneic hematopoietic cell transplantation

    Article • Annals of Hematology, August 2020, Springer Science + Business Media

    Dr Yuho Najima

  129. Prognostic impact of TP53 mutation, monosomal karyotype, and prior myeloid disorder in nonremission acute myeloid leukemia at allo-HSCT

    Article • Bone Marrow Transplantation, August 2020, Springer Science + Business Media

    Dr Yuho Najima

  130. Nontuberculous mycobacterial bloodstream infections after allogeneic hematopoietic stem cell transplantation

    Article • International Journal of Infectious Diseases, August 2020, Elsevier

    Dr Yuho Najima

  131. Geriatric nutritional risk index as a useful prognostic factor in second allogeneic hematopoietic stem cell transplantation

    Article • Annals of Hematology, June 2020, Springer Science + Business Media

    Dr Yuho Najima

  132. Bone turnover markers as an aid to monitor osteoporosis following allogeneic hematopoietic stem cell transplantation

    Article • Annals of Hematology, May 2020, Springer Science + Business Media

    Dr Yuho Najima

  133. Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leukemi...

    Article • Bone Marrow Transplantation, May 2020, Springer Science + Business Media

    Dr Yuho Najima

  134. Allogeneic hematopoietic cell transplantation for adults with acute myeloid leukemia conducted in Japan during the past quarter century

    Article • Annals of Hematology, May 2020, Springer Science + Business Media

    Dr Yuho Najima

  135. Outcomes and Prognostic Factors for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A KSGCT Multicenter Analysis

    Article • Biology of Blood and Marrow Transplantation, May 2020, Elsevier

    Dr Yuho Najima

  136. Late appearance of eosinophilia in myeloid blast phase of myeloid neoplasm with rearrangement of PDGFRβ

    Article • Leukemia & Lymphoma, February 2020, Taylor & Francis

    Dr Yuho Najima

  137. Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia harboring t(1;19)(q23;p13.3); comparison with normal karyotype

    Article • Bone Marrow Transplantation, February 2020, Springer Science + Business Media

    Dr Yuho Najima

  138. The sensitivity of the FLT3-ITD detection method is an important consideration when diagnosing acute myeloid leukemia

    Article • Leukemia Research Reports, January 2020, Elsevier

    Dr Yuho Najima

  139. Allogeneic hematopoietic stem cell transplantation for aplastic anemia with pre‐transplant conditioning using fludarabine, reduced‐dose cyclophosphamide, and low‐dose thymoglobulin: A KSGCT prospective study

    Article • American Journal of Hematology, December 2019, Wiley

    Dr Yuho Najima

  140. The emergence of rare nocardiosis following allogeneic hematopoietic stem cell transplantation in the era of molecular taxonomy

    Article • International Journal of Infectious Diseases, December 2019, Elsevier

    Dr Yuho Najima

  141. Unmanipulated haploidentical hematopoietic stem cell transplantation using very low-dose antithymocyte globulin and methylprednisolone in adults with relapsed/refractory acute leukemia

    Article • Annals of Hematology, November 2019, Springer Science + Business Media

    Dr Yuho Najima

  142. Clinical and Genetic Characteristics of Adolescent and Young Adult Patients with Myelodysplastic Syndromes

    Article • Blood, November 2019, American Society of Hematology

    Dr Yuho Najima

  143. Clinical and Genetic Features of Constitutional Partial Trisomy 8 Mosaicism (CT8M) Patients with Cytopenia

    Article • Blood, November 2019, American Society of Hematology

    Dr Yuho Najima

  144. Clonal Dynamics and Publicness of CMV-Specific TCR Repertoire after Allogeneic Stem Cell Transplantation

    Article • Blood, November 2019, American Society of Hematology

    Dr Yuho Najima

  145. Post-Transplant Maintenance Treatment with Ponatinib for Philadelphia Chromosome Positive Leukemia

    Article • Blood, November 2019, American Society of Hematology

    Dr Yuho Najima

  146. The Presence of Minimal Residual Disease, As Determined By Highly Sensitive Quantitation of NPM1-Mutatation, Provided Powerful Prognostic Information in Acute Myeloid Leukemia

    Article • Blood, November 2019, American Society of Hematology

    Dr Yuho Najima

  147. Weight Adjusted Urinary Creatinine Excretion Predicts Transplant Outcomes in Adult Patients with Acute Myeloid Leukemia in Complete Remission

    Article • Blood, November 2019, American Society of Hematology

    Dr Yuho Najima

  148. A case of polycythemia vera diagnosed after postextraction hemorrhage

    Article • Japanese Journal of Oral & Maxillofacial Surgery, September 2019, Japanese Society of Oral and Maxillofacial Surgeons

    Dr Yuho Najima

  149. Allogeneic hematopoietic cell transplantation in patients with untreated acute myeloid leukemia: a KSGCT multicenter retrospective analysis

    Article • Bone Marrow Transplantation, September 2019, Springer Science + Business Media

    Dr Yuho Najima

  150. Significance of FLT3-tyrosine kinase domain mutation as a prognostic factor for acute myeloid leukemia

    Article • International Journal of Hematology, August 2019, Springer Science + Business Media

    Dr Yuho Najima

  151. The Authors' Reply to "The Addition of Prophylactic Antibiotics Can Achieve a Favorable Outcome"

    Article • Internal Medicine, August 2019, Japanese Society of Internal Medicine

    Dr Yuho Najima

  152. Prognostic index for patients with relapsed or refractory acute myeloid leukemia who underwent hematopoietic cell transplantation: a KSGCT multicenter analysis

    Article • Leukemia, May 2019, Springer Science + Business Media

    Dr Yuho Najima

  153. Nutritional risk index as a risk factor for breakthrough candidemia in allogeneic hematopoietic stem cell transplantation

    Article • Bone Marrow Transplantation, May 2019, Springer Science + Business Media

    Dr Yuho Najima

  154. Disseminated adenovirus infection in a patient with relapsed refractory multiple myeloma undergoing autologous stem cell transplantation and pomalidomide/dexamethasone as salvage regimens

    Article • Journal of Infection and Chemotherapy, May 2019, Elsevier

    Dr Yuho Najima

  155. Successful hematopoietic stem-cell mobilization with plerixafor plus granulocyte-colony stimulating factor in multiple myeloma patients treated with pomalidomide

    Article • International Journal of Hematology, April 2019, Springer Science + Business Media

    Dr Yuho Najima

  156. Geriatric nutritional risk index (GNRI) just before allogeneic hematopoietic stem cell transplantation predicts transplant outcomes in patients older than 50 years with acute myeloid leukemia in complete remission

    Article • Annals of Hematology, March 2019, Springer Science + Business Media

    Dr Yuho Najima

  157. Co-activation of macrophages and T cells contribute to chronic GVHD in human IL-6 transgenic humanised mouse model

    Article • EBioMedicine, March 2019, Elsevier

    Dr Yuho Najima

  158. Efficacy and Safety of a Weekly Cyclophosphamide-Bortezomib-Dexamethasone Regimen as Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma: A Phase 2 Multicenter Trial

    Article • Acta Haematologica, January 2019, Karger Publishers

    Dr Yuho Najima

  159. Fatal Neutropenic Enterocolitis Caused by <i>Stenotrophomonas maltophilia</i>: A Rare and Underrecognized Entity

    Article • Internal Medicine, December 2018, Japanese Society of Internal Medicine

    Dr Yuho Najima

  160. Reassessment of clinical implication of pretransplant surgical procedures for pulmonary invasive fungal lesions

    Article • Transplant Infectious Disease, November 2018, Wiley

    Dr Yuho Najima

  161. Clinical Efficacy of Prebiotics on Transplant-Related Complications

    Article • Blood, November 2018, American Society of Hematology

    Dr Yuho Najima

  162. Combining the Number of Infectious Episodes and Interval of Chemotherapy to Transplantation May Predict a Transplant Outcome in Patients with Acute Myeloid Leukemia: A Retrospective Analysis of JALSG AML201 Study

    Article • Blood, November 2018, American Society of Hematology

    Dr Yuho Najima

  163. Efficacy and Safety of Once-Weekly Cyclophosphamide-Bortezomib-Dexamethasone (CBD) Regimen As Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma. -a Phase 2 Multicenter Trial-

    Article • Blood, November 2018, American Society of Hematology

    Dr Yuho Najima

  164. Presence of TP53 Mutation and Monosomal Karyotype Predict the Outcome of Patients with Acute Myeloid Leukemia in Non-Remission at Allogeneic Stem Cell Transplantation

    Article • Blood, November 2018, American Society of Hematology

    Dr Yuho Najima

  165. Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia

    Article • Blood Advances, October 2018, American Society of Hematology

    Dr Yuho Najima

  166. Allogeneic hematopoietic cell transplantation in adult acute myeloid leukemia with 11q23 abnormality: a retrospective study of the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)

    Article • Annals of Hematology, July 2018, Springer Science + Business Media

    Dr Yuho Najima

  167. Deregulated Mucosal Immune Surveillance through Gut-Associated Regulatory T Cells and PD-1+ T Cells in Human Colorectal Cancer

    Article • The Journal of Immunology, May 2018, The American Association of Immunologists

    Dr Yuho Najima

  168. Outcome of patients with acute undifferentiated leukemia after allogeneic hematopoietic stem cell transplantation

    Article • Leukemia & Lymphoma, April 2018, Taylor & Francis

    Dr Yuho Najima

  169. Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia

    Article • Biology of Blood and Marrow Transplantation, April 2018, Elsevier

    Dr Yuho Najima

  170. Regulatory T cell inhibition by dasatinib is associated with natural killer cell differentiation and a favorable molecular response—The final results of the D-first study

    Article • Leukemia Research, March 2018, Elsevier

    Dr Yuho Najima

  171. A prospective multicenter phase II study of intrabone marrow transplantation of unwashed cord blood using reduced-intensity conditioning

    Article • European Journal Of Haematology, January 2018, Wiley

    Dr Yuho Najima

  172. Deferasirox for the treatment of iron overload after allogeneic hematopoietic cell transplantation: multicenter phase I study (KSGCT1302)

    Article • International Journal of Hematology, January 2018, Springer Science + Business Media

    Dr Yuho Najima

  173. Outcomes after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia harboring t(7;11)(p15;p15)

    Article • Haematologica, November 2017, Ferrata Storti Foundation (Haematologica)

    Dr Yuho Najima

  174. Peripheral nerve injury following allogeneic hematopoietic stem cell transplantation

    Article • Journal of the Neurological Sciences, October 2017, Elsevier

    Dr Yuho Najima

  175. Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantation

    Article • BMC Infectious Diseases, September 2017, Springer Science + Business Media

    Dr Yuho Najima

  176. Clinical impact of pre-transplant gut microbial diversity on outcomes of allogeneic hematopoietic stem cell transplantation

    Article • Annals of Hematology, July 2017, Springer Science + Business Media

    Dr Yuho Najima, Yutaka Shimazu

  177. Diagnostic open brain biopsy following initial negative results of cerebrospinal fluid assessment forToxoplasma

    Article • Transplant Infectious Disease, March 2017, Wiley

    Dr Yuho Najima

  178. Central nervous system infection following allogeneic hematopoietic stem cell transplantation

    Article • Hematology/Oncology and Stem Cell Therapy, March 2017, King Faisal Specialist Hospital and Research Centre - DIGITAL COMMONS JOURNALS

    Dr Yuho Najima

  179. Erythrocytosis after allogeneic hematopoietic stem cell transplantation

    Article • Clinical Transplantation, February 2017, Wiley

    Dr Yuho Najima

  180. Impact of Human Leukocyte Antigen Allele Mismatch in Unrelated Bone Marrow Transplantation with Reduced-Intensity Conditioning Regimen

    Article • Biology of Blood and Marrow Transplantation, February 2017, Elsevier

    Dr Yuho Najima

  181. Extramedullary Gastric Relapse at the Time of Bone Marrow Relapse of Acute Lymphoblastic Leukemia after Allogeneic Bone Marrow Transplantation

    Article • Internal Medicine, January 2017, Japanese Society of Internal Medicine

    Dr Yuho Najima

  182. Mesenchymal Stem Cells: The First Approved Stem Cell Drug in Japan

    Article • Journal of Hematopoietic Cell Transplantation, January 2017, The Japan Society for Hematopoietic Stem Cell Transplantation

    Dr Yuho Najima

  183. Central Nervous System Involvement at the Time of Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with a Poor Outcome in Patients with Acute Myeloid Leukemia

    Article • Pathology & Oncology Research, December 2016, Springer Science + Business Media

    Dr Yuho Najima

  184. the Safety and Efficacy of Deferasirox for the Transplant Patients with Iron Overload

    Article • Blood, December 2016, American Society of Hematology

    Dr Yuho Najima

  185. Clinical Impact of Pre-Transplant Microbial Diversity on Transplant Outcomes

    Article • Blood, December 2016, American Society of Hematology

    Dr Yuho Najima

  186. Association of Peripheral Regulatory T Cells with Achievement of Deep Molecular Response in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Treated with Dasatinib - the Final Results of D-First Study

    Article • Blood, December 2016, American Society of Hematology

    Dr Yuho Najima

  187. Growth Suppressing Activity of Lhx2 in Human T Cell Acute Lymphoblastic Leukemia (T-ALL)-Derived Cells and Large-Scale Screening of a Lead Compounds Targeting T-ALL

    Article • Blood, December 2016, American Society of Hematology

    Dr Yuho Najima

  188. Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia Harboring t(7;11)(p15;p15)

    Article • Blood, December 2016, American Society of Hematology

    Dr Yuho Najima

  189. Mycophenolate mofetil is effective only for involved skin in the treatment for steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

    Article • Annals of Hematology, October 2016, Springer Science + Business Media

    Dr Yuho Najima

  190. Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut

    Article • Blood, October 2016, American Society of Hematology

    Dr Yuho Najima

  191. Comparison of transplant outcomes and economic costs between biosimilar and originator filgrastim in allogeneic hematopoietic stem cell transplantation

    Article • International Journal of Hematology, August 2016, Springer Science + Business Media

    Dr Yuho Najima

  192. Clinical utility of high-flow nasal cannula oxygen therapy for acute respiratory failure in patients with hematological disease

    Article • SpringerPlus, April 2016, Springer Science + Business Media

    Dr Yuho Najima

  193. Induction of WT1-specific human CD8+ T cells from human HSCs in HLA class I Tg NOD/SCID/IL2rgKO mice

    Article • Blood, February 2016, American Society of Hematology

    Dr Yuho Najima

  194. Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: A nationwide retrospective study

    Article • Leukemia Research, February 2016, Elsevier

    Dr Yuho Najima

  195. Comparison of Outcomes of 8/8 and 7/8 Allele–Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia

    Article • Biology of Blood and Marrow Transplantation, February 2016, Elsevier

    Dr Yuho Najima

  196. Allogeneic hematopoietic stem cell transplant overcomes poor prognosis of acute myeloid leukemia with myelodysplasia-related changes

    Article • Leukemia & Lymphoma, January 2016, Taylor & Francis

    Dr Yuho Najima

  197. Severe Hypoxemia in a Healthy Donor for Allogeneic Hematopoietic Stem Cell Transplantation after Only the First Administration of Granulocyte-Colony Stimulating Factor

    Article • Transfusion Medicine and Hemotherapy, January 2016, Karger Publishers

    Dr Yuho Najima

  198. Occurrence of Donor Cell-derived Lymphoid Blast Crisis 24 Years Following Related Bone Marrow Transplantation for Chronic Myeloid Leukemia

    Article • Internal Medicine, January 2016, Japanese Society of Internal Medicine

    Dr Yuho Najima

  199. CD25 expression on residual leukemic blasts at the time of allogeneic hematopoietic stem cell transplant predicts relapse in patients with acute myeloid leukemia without complete remission

    Article • Leukemia & Lymphoma, December 2015, Taylor & Francis

    Dr Yuho Najima

  200. Clinical impact of hematogones on outcomes of allogeneic hematopoietic stem cell transplantation

    Article • Annals of Hematology, September 2015, Springer Science + Business Media

    Dr Yuho Najima

  201. Early-onset acute kidney injury is a poor prognostic sign for allogeneic SCT recipients

    Article • Bone Marrow Transplantation, August 2015, Springer Science + Business Media

    Dr Yuho Najima

  202. Dasatinib-induced gastric antral vascular ectasia in a patient with acute lymphoblastic leukaemia

    Article • British Journal of Haematology, April 2015, Wiley

    Dr Yuho Najima

  203. The Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) for Elderly Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) in the Era of Tyrosine Kinase Inhibitor (TKI) : A Single Institute Experience

    Article • Biology of Blood and Marrow Transplantation, February 2015, Elsevier

    Dr Yuho Najima

  204. Post-transplant maintenance therapy with azacitidine and gemtuzumab ozogamicin for high-risk acute myeloid leukaemia

    Article • British Journal of Haematology, December 2014, Wiley

    Dr Yuho Najima

  205. Urinary Liver-Type Fatty Acid-Binding Protein Linked with Increased Risk of Acute Kidney Injury after Allogeneic Stem Cell Transplantation

    Article • Biology of Blood and Marrow Transplantation, December 2014, Elsevier

    Dr Yuho Najima

  206. Toxic encephalopathy after exposure to azacitidine

    Article • Leukemia & Lymphoma, November 2014, Taylor & Francis

    Dr Yuho Najima

  207. Contribution of Bone Marrow-Derived Hematopoietic Stem/Progenitor Cells to the Generation of Donor-Marker+ Cardiomyocytes In Vivo

    Article • PLOS One, May 2013, PLOS

    Dr Yuho Najima

  208. A Pyrrolo-Pyrimidine Derivative Targets Human Primary AML Stem Cells in Vivo

    Article • Science Translational Medicine, April 2013, American Association for the Advancement of Science

    Dr Yuho Najima, Dr. Akiko Tanaka

  209. Il2rg Gene-Targeted Severe Combined Immunodeficiency Pigs

    Article • Cell Stem Cell, June 2012, Elsevier

    Dr Yuho Najima, Dr Tony Perry

  210. Incidence, risk factors, and clinical outcomes of cataracts following hematopoietic stem cell transplantation

    Article • American Journal of Hematology, April 2011, Wiley

    Dr Yuho Najima

  211. Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rγnullhumanized mice

    Article • Proceedings of the National Academy of Sciences, July 2010, Proceedings of the National Academy of Sciences

    Dr Yuho Najima

  212. Molecular monitoring of BAALC expression in patients with CD34-positive acute leukemia

    Article • International Journal of Hematology, April 2010, Springer Science + Business Media

    Dr Yuho Najima

  213. Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML

    Article • Nature Biotechnology, February 2010, Springer Science + Business Media

    Dr Yuho Najima

  214. Identification of Therapeutic Targets for Quiescent, Chemotherapy-Resistant Human Leukemia Stem Cells

    Article • Science Translational Medicine, February 2010, American Association for the Advancement of Science

    Dr Yuho Najima

  215. Cell Cycle Entry Potentiates Elimination of Chemotherapy-Resistant Human AML Stem Cells.

    Article • Blood, November 2009, American Society of Hematology

    Dr Yuho Najima

  216. Intracranial hemorrhage following allogeneic hematopoietic stem cell transplantation

    Article • American Journal of Hematology, May 2009, Wiley

    Dr Yuho Najima

  217. Quantitative Monitoring of T315I BCR-ABL Mutation by the Invader Assay.

    Article • Blood, November 2007, American Society of Hematology

    Dr Yuho Najima

  218. Molecular Monitoring of ERG and BAALC as Minimal Residual Disease Markers in Patients with Acute Leukemia.

    Article • Blood, November 2007, American Society of Hematology

    Dr Yuho Najima

  219. Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma

    Article • European Journal of Cancer, June 2005, Elsevier

    Dr Yuho Najima

  220. High Mobility Group Protein-B1 Interacts with Sterol Regulatory Element-binding Proteins to Enhance Their DNA Binding

    Article • Journal of Biological Chemistry, May 2005, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Yuho Najima

  221. p53 Involvement in the Pathogenesis of Fatty Liver Disease

    Article • Journal of Biological Chemistry, February 2004, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Yuho Najima

  222. Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression

    Article • Hepatology, December 2003, Wiley

    Dr Yuho Najima

  223. p53 Activation in Adipocytes of Obese Mice

    Article • Journal of Biological Chemistry, May 2003, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr Yuho Najima